Text: S.2796 — 115th Congress (2017-2018)All Information (Except Text)

There is one version of the bill.

Text available as:

Shown Here:
Introduced in Senate (05/07/2018)


115th CONGRESS
2d Session
S. 2796


To authorize the Secretary of Veterans Affairs to use the authority of the Secretary to conduct and support research on the efficacy and safety of medicinal cannabis, and for other purposes.


IN THE SENATE OF THE UNITED STATES

May 7, 2018

Mr. Tester (for himself and Mr. Sullivan) introduced the following bill; which was read twice and referred to the Committee on Veterans' Affairs


A BILL

To authorize the Secretary of Veterans Affairs to use the authority of the Secretary to conduct and support research on the efficacy and safety of medicinal cannabis, and for other purposes.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. Short title.

This Act may be cited as the “VA Medicinal Cannabis Research Act of 2018”.

SEC. 2. Conduct of research into effects of cannabis on health outcomes of certain veterans.

(a) Research required.—In carrying out the responsibilities of the Secretary of Veterans Affairs under section 7303 of title 38, United States Code, the Secretary may conduct and support research relating to the efficacy and safety of forms of cannabis described in subsection (c) on the health outcomes of covered veterans diagnosed with chronic pain, post-traumatic stress disorder, and other conditions the Secretary determines appropriate.

(b) Data preservation.—Research conducted pursuant to subsection (a) shall include a mechanism to ensure the preservation of all data, including all data sets, collected or used for purposes of the research required by subsection (a) in a manner that will facilitate further research.

(c) Forms of cannabis To be researched.—The forms of cannabis described in this subsection are—

(1) varying forms of cannabis, including—

(A) full plants and extracts;

(B) at least three different strains of cannabis with significant variants in phenotypic traits and various ratios of tet­ra­hy­dro­can­nab­i­nol and cannabidiol in chemical composition; and

(C) other chemical analogs of tet­ra­hy­dro­can­nab­i­nol; and

(2) varying methods of cannabis delivery, including topical application, combustible and non-combustible inhalation, and ingestion.

(d) Implementation.—Not later than 180 days after the date of the enactment of this Act, the Secretary shall—

(1) develop a plan to implement this section and submit such plan to the Committees on Veterans’ Affairs of the House of Representatives and the Senate; and

(2) issue any requests for proposals the Secretary determines appropriate for such implementation.

(e) Reports.—During the five-year period beginning on the date of the enactment of this Act, the Secretary shall submit periodically, but not less frequently than annually, to the Committees on Veterans’ Affairs of the House of Representatives and the Senate reports on the implementation of this section.

(f) Covered veteran defined.—In this section, the term “covered veteran” means a veteran who is enrolled in the patient enrollment system of the Department of Veterans Affairs under section 1705 of title 38, United States Code.